Amidst the coronavirus epidemic, the US will start a clinical trial of the vaccine to protect the coronavirus from today
The deadly coronavirus is spreading rapidly in countries around the world after China. Amidst this pandemic, the US will begin clinical trials of the vaccine to protect the coronavirus from today.
A government official, on the condition of anonymity, said that the first participant for the trial would be vaccinated on Monday. He said that the trial has not been announced publicly yet. The National Institute of Health Trial is funding this. It is being trialed at the Kaiser Permanente Washington Health Research Institute in Seattle. Public health officials say it will take from one year to 18 months to fully validate any potential vaccine.
Test on 45 youth
Different doses of the drug, co-developed by NIH and Modern Inc., will be started with 45 healthy youth. There is no risk of any participants getting infected by Dao, as they themselves will not get infected by the virus. The main purpose of the test is to check if there are any side effects of the vaccine. So that it can be tested in large numbers.
Work on temporary vaccines for viruses
Let me tell you that a group of dozens of researchers from all over the world are in the race to make the coronavirus vaccine because its cases are steadily increasing. Some researchers are also working on temporary vaccines, which can protect people’s health for a month or two. Unless there is no sure cure for the virus.
Till date, more than 5800 people have died
More than 156,000 people have been infected by the worldwide coronavirus, while more than 5,800 people have died. At the same time, according to the World Health Organization, people with fewer infections recover in about two weeks, while those with more severe infections may take from three weeks to six weeks to recover.